Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy by Kuwahara, Y et al.
Enhancement of autophagy is a potential modality for
tumors refractory to radiotherapy
Y Kuwahara
1, T Oikawa
1, Y Ochiai
1, MH Roudkenar
2, M Fukumoto
1, T Shimura
1, Y Ohtake
3, Y Ohkubo
3, S Mori
4, Y Uchiyama
5
and M Fukumoto*
,1
Radiotherapy is a well-established treatment for cancer. However, the existence of radioresistant cells is one of the major
obstacles in radiotherapy. In order to understand the mechanism of cellular radioresistance and develop more effective
radiotherapy, we have established clinically relevant radioresistant (CRR) cell lines, which continue to proliferate under daily
exposure to 2 Gray (Gy) of X-rays for 430 days. X-ray irradiation signiﬁcantly induced autophagic cells in parental cells, which
was exiguous in CRR cells, suggesting that autophagic cell death is involved in cellular radiosensitivity. An autophagy inducer,
rapamycin sensitized CRR cells to the level of parental cells and suppressed cell growth. An autophagy inhibitor,
3-methyladenineinducedradioresistanceofparentalcells.Furthermore,inhibition ofautophagybyknockdownofBeclin-1made
parental cells radioresistant to acute radiation. These suggest that the suppression of autophagic cell death but not apoptosis is
mainly involved in cellular radioresistance. Therefore, the enhancement of autophagy may have a considerable impact on the
treatment of radioresistant tumor.
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Radiotherapy and radiochemotherapy are well-established
treatment modalities for various cancers. Tumor cells have
the capacity to cope with radiotherapy and chemotherapy
through multiple pathways of growth arrest and cell death.
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Various modes of cell death have been known, such as
necrosis, apoptosis, accelerated senescence, mitotic cata-
strophe and autophagic cell death.
2–4 Among these, apoptosis
has been the most extensively studied and has revealed to be
the primary mode of cell death in leukemia and lymphoma
cells.
5 However, the concept of cell death is continuously
evolving and the role of apoptosis in radiation or anticancer
drug treatment is being reappraised.
6 Although death after
irradiationinleukemiaandlymphomaisprecededbyapoptotic
changes, apoptosis has little or even no role in the killing of
epithelial neoplastic cells by radiation.
7 Moreover, early
response of cell death, apoptosis is not necessarily correlated
with overall tumor sensitivity to anticancer treatment.
8,9
Compared with other cell death patterns, autophagy
induced by radiation or anticancer drugs is less studied.
4
Dual role of autophagy has been reported, cell death and
survival. Therefore, autophagy is considered to be a double-
edged sword in the process of tumor development.
10
Autophagy suppresses tumor formation by triggering a non-
apoptotic cell death program. The Beclin-1 gene, an ortholog
of Apg6, which participates in the induction of autophagy
in response to starvation is reported to be one of tumor-
suppressor genes.
11 On the contrary, the activation of
autophagy may permit cancer cells to survive within the
nutrient-poor environment.
12 Anticancer drug-induced auto-
phagy can lead either to cell death or alternatively to
protection against cell death. An anticancer drug, tamoxifen
induces autophagic cell death in human mammary carcinoma
MCF-7 cells.
13 By contrast, in response to sulindac and tumor
necrosis factor-a, autophagy is induced as a cell survival
mechanism.
14–16 Autophagy may protect some cancer cells
from ionizing radiation possibly by removing damaged
macromolecules and organelles such as mitochondria, which
could protect against apoptosis and allow continued survival
of transformed cells.
17 Ionizing radiation does not induce
apoptosis but induces autophagic changes in glioblastoma
cell lines irrespective of their relative radiosensitivity.
18 It is
suggested that a basal enhanced level of autophagy in cancer
cells contributes to therapy resistance but prolonged activa-
tion of autophagy may lead to cell death by cellular self-
degradation.
19
In order to develop more effective tumor radiotherapy, we
have recently established clinically relevant radioresistant
(CRR) cell lines, HepG2-8960-R and HepG2-R from HepG2,
and SAS-R from SAS, independently.
20,21 These cells
continue to proliferate with daily exposure to 2 Gray (Gy) of
X-rays for 430 days, which corresponds to the standard
protocol of fractionated radiotherapy for cancer treatment.
This study revealed that CRR cells were refractory to the
induction of autophagy after irradiation and that facilitation of
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type. We also found that repression of autophagy induced
radioresistance in non-CRR parental cells.
Results
Microscopic analysis of radiation-induced cell death
after acute exposure to 10Gy of X-rays. We pursued
morphological changes characteristic to radiation-induced
cell death. Within 2 days after 10Gy of acute radiation (AR),
prominent changes in morphology were not observed in
HepG2 cells other than a slight increase in the cell size
(Figures 1a–c). At day 3 after AR, the number of round cells,
that is, mitotic cells increased (Figure 1d). Thereafter dead
cells became obvious and multinucleated cells, characteristic
to mitotic catastrophe, were also observed (Figures 1e and f).
Dying cells were classiﬁed into two types: apoptotic cells
with apoptotic bodies (Figure 1g) and non-apoptotic cells
without apoptotic bodies (Figure 1h). The frequency of
non-apoptotic cells was signiﬁcantly higher than that of
apoptotic cells.
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Figure 1 Microscopic appearance of parental HepG2 cells after exposure to a single dose of 10-Gy X-rays. (a) Mitotic ﬁgures but a few were observed in HepG2 cells
withoutirradiation.(b)Noremarkablechangesbuttheincreaseincellsizewereobserved1dayafterexposure.(c)Theincreaseincellsizewasobvious2daysafterexposure.
(d) Mitotic ﬁgures were apparent 3 days after exposure (black arrows). (e) At day 5 after exposure, a frequent number of dying cells were seen (black arrow heads).
Multinucleatedcellsshowingmitoticcatastrophewerealsoincreased(whitearrows).(f)Atday7afterexposure.(g)Deadcellswithapoptoticbodies(arrowheads;5daysafter
exposure to X-rays). (h) Dead cell without apoptotic bodies (arrow head; 5 days after exposure to X-rays)
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Cell Death and DiseaseBasal levels of dead cells were higher in radioresistant
HepG2-8960-R than HepG2 (Figure 2a), presumably due to
maintenance irradiation at 2Gy per day. During this experi-
mental period, distinguishable induction of cell death was not
observed (Figures 2a–f). At day 3 after AR, inconsiderable
increase in non-apoptotic cell death was observed in HepG2-
8960-R (Figure 2d). After that no increase in either dead cells
ormitoticcatastrophewasobserved(Figures2eandf).These
suggested that apoptosis is not a major type of cell death
induced by ionizing radiation.
To examine to what extent X-ray exposure induces
apoptotic changes, apoptotic cell death was evaluated by
different methods. Basal level of annexin V-positive apoptotic
cells observed under a microscope was signiﬁcantly higher in
HepG2-8960-R than in HepG2 (Figure 3a). AR of 10Gy
increased the frequency of annexin V-positive cells both in
HepG2 and HepG2-8960-R. The increase was faster and
higher in HepG2-8960-R than that in HepG2. The maximum
level was about 20% in HepG2-8960-R and 10% in HepG2.
ThefrequencyofannexinV-positivecellswasconstantinboth
cell lines after reaching the maximal level. On the other hand,
fractionated radiation (FR) of 2Gy per day did not induce
signiﬁcant frequency of annexin V-positive cells both in
HepG2 and HepG2-8960-R (Figure 3b). We next examined
DNA ladder formation, a hallmark of apoptosis. Although
5 days after AR, many dead cells were observed in the cell
culture(Figure1e),DNAladderformation wasnotobservedin
both HepG2 and HepG2-8960-R at any time examined
(Supplementary Figure S1A). Radiation-induced DNA ladder
formation was not detectable in SAS and SAS-R (Supple-
mentary Figure S1B). We further examined the expression of
cleaved caspase 3 after irradiation. After AR, signiﬁcant
increase in cleaved caspase 3 was not detectable by western
blotting from 0 to 7 days after AR in all cell lines examined
(data not shown). Radiosensitivity under the inhibition of
apoptosis by Z-VAD-FMK was evaluated. The inhibition of
apoptosis sensitized both HepG2 and HepG2-8960-R to
X-rays slightly at lower doses and signiﬁcantly at 10Gy
(Supplementary Figures S2A and B). However, the inhibition
of apoptosis did not affect surviving fractions of SAS and
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Figure 2 MicroscopicappearanceofradioresistantHepG2-8960-Rcells afteracuteexposureto 10Gyof X-rays.(a)HepG2-8960-Rcells2 daysafterexposureto 2Gy of
X-rays (maintenance irradiation). Mitotic cells (black arrows), dead cells (black arrow heads) and multinucleated cells showing mitotic catastrophe (white arrows) were
observed. (b) No remarkable changes were observed 1 day after exposure to 10Gy of X-rays. (c) Unlike HepG2 cells the increase in cell size was not obvious 2 days after
exposure to10GyofX-rays.(d)Mitoticﬁgureswerenotapparentcomparedwith HepG2cells3daysafterexposureto10Gyof X-rays.(e)At day5 afterexposureto 10Gyof
X-rays, the frequency of dead cells was lower compared with HepG2. (f) At day 7 after exposure to 10Gy of X-rays, the number of cells in mitotic catastrophe was not
increased
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Cell Death and DiseaseSAS-R (Supplementary Figures S2C and D). These results
indicated that contribution of apoptosis to cellular radio-
sensitivity is lower than previously considered.
Autophagy induced by X-ray exposure. We analyzed
immunocytochemically positive cells for LC-3, a marker of
autophagosomes. AR induced cells whose cytoplasm was
ﬁlled with autophagosomes both in HepG2 and HepG2-8960-R
(Figure 4). We deﬁned these characteristic cells as
‘hyperinduced autophagic cells’ (Figures 4b and c). The
frequency of hyperinduced autophagic cells in HepG2-8960-R
(24.0±5.2%) was signiﬁcantly higher than that in HepG2
(1.5±0.7%). Within 24h after AR of 10Gy, hyperinduced
autophagic cells did not increase in both HepG2 and HepG2-
8960-R (Supplementary Figure S3). Electron microscopic
observation also conﬁrmed that autophagic cell death was
induced both in HepG2 and HepG2-8960-R by AR (Figures
4e–h). The frequency of hyperinduced autophagic cells in
HepG2 gradually increased from day 3 and reached
78.2±6.1% at day 7 after AR (Figure 5a). On the contrary,
marked induction of hyperinduced autophagic cells was not
observed in HepG2-8960-R and the frequency was
40.9±8.6% at day 7. Exposure to 5 2Gy of FR remarkably
induced hyperinduced autophagic cells in HepG2 (45.9±6.9%)
but not in HepG2-8960-R (24.2±1.8%; Figure 5b). We next
examined the conversion of LC3-I to LC3-II, which is an
indicator of autophagic activity and the amount of LC3-II
correlates well with the number of autophagosomes.
22 At day 5
after AR, LC3-II level increased in both HepG2 and HepG2-
8960-R, and the induction level was higher in HepG2 than in
HepG2-8960-R (Figure 5c). We further examined the
expression level of p62, which accumulates when autophagy
is inhibited and decreases when autophagy is induced.
23
Without irradiation the expression level of p62 in HepG2 was
higher than that in HepG2-8960-R (Figure 5d). The expression
of p62 in HepG2 remained reduced from day 3 to 7 after AR
and that in HepG2-8960-R reduced at day 3 but returned to the
basal level by day 7.
Radiosensitization of CRR cells via induction of
autophagy. Radiosensitivity after facilitation of autophagy
by RPM was evaluated. Chronic exposure to radiation
reduces plating efﬁciency on which reproducibility of
clonogenic assay depends. Therefore, in this study the
modiﬁed high-density survival (HDS) assay instead of
clonogenic assay was used to determine cellular
radiosensitivity. HepG2-8960-R and all other CRR cell lines
examined were signiﬁcantly radioresistant compared with
their corresponding parental cell lines (Figure 6a,
Supplementary Figure S4). Radiosensitivity of HepG2-
8960-R with RPM treatment became almost the same as
that of HepG2 (Figure 6b). RPM also sensitized both HepG2-
R and SAS-R (Supplementary Figures S4B and D) and its
radiosensitizing effect tended to be higher at higher doses.
Radiosensitivity of HepG2 with or without RPM was not
signiﬁcantly different (Supplementary Figure S5A). The
inhibition of autophagy by 3-methyladenine (3-MA) did not
radiosensitize HepG2-8960-R (Supplementary Figure S5D),
but made HepG2 radioresistant to the level of HepG2-8960-R
and even more resistant than HepG2-R (Figure 6C and
Supplementary Figure S6B). Radioresistance was also
induced in SAS by 3-MA (Supplementary Figure S6D).
However, these effects were not observed in both HepG2-R
and SAS-R (Supplementary Figures S6B and D).
Autophagy induced by FR. RPM at the concentration of
10ng/ml for 5 days was not toxic to HepG2 (Figure 7a), but
signiﬁcantly suppressed cell growth of HepG2-8960-R at
day 5 (Figure 7b). FR alone suppressed cell growth of
HepG2 (Supplementary Figure S7A), but additional
radiosensitizing effect of RPM was not detected
(Figure 7c). On the other hand, cell growth of HepG2-8960-
R was drastically suppressed by the administration of FR and
RPM (Figure 7d) and this effect was reinforced by FR
(Supplementary Figure S7D).
CellgrowthofHepG2wassuppressedby3-MA(Figure7e).
The effect of 3-MA on the cell growth was not obvious in
HepG2-8960-R (Figure 7f). Radiosensitizing effect of 3-MA
on FR was not observed both in HepG2 (Figure 7g,
Supplementary Figure S7E) and in HepG2-8960-R
(Figure 7h, Supplementary Figure S7F).
Radiosensitizing effect of RPM was also conﬁrmed in
HepG2-R and SAS-R cells but not in SAS cells, indicating that
the CRR phenotype is reversed by RPM (Supplementary
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Cell Death and DiseaseFigures S8B, D and F). On the other hand, administration of
3-MA conferred radioresistance on SAS against FR (Supple-
mentary Figure S8D).
We next examined whether administration of RPM or 3-MA
induces apoptosis, mitotic catastrophe or hyperinduced
autophagic cells. At day 5 after irradiation, the frequency of
annexin V-positive cells was not signiﬁcantly different
between with or without RPM or 3-MA (Supplementary Figure
S9A). The induction frequency of mitotic catastrophe was not
different between HepG2 and HepG2-8960-R irrespective of
RPM or 3-MA treatments (Supplementary Figure S9B).
Although RPM increased the frequency of hyperinduced
autophagic cells in HepG2-8960-R 7 days after AR, un-
expectedly did not in HepG2. Administration of 3-MA
suppressed X-ray-induced hyperinduced autophagic cells in
HepG2 (Supplementary Figure 9C).
Beclin-1 knockdown and radiosensitivity. We further
examined whether inhibition of autophagy by knockdown of
Beclin-1 induces radioresistance or not. We used psiRNA-
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Figure 4 (a–d) Representative ﬁgures of hyperinduced autophagic cells by a single dose of 10-Gy X-rays in parental HepG2 and radioresistant HepG2-8960-R cells.
Autophagosomeswereimmunocytochemicallyvisualizedbyanti-LC-3antibodyandcellsﬁlledwithautophagosomeswerecountedashyperinducedautophagiccells(arrows).
(e–h) Electron microscopic analysis of HepG2 and HepG2-8960-R. (a) Hyperinduced autophagic cells were seldom observed in HepG2 cells without irradiation. (b) At day 7
after exposure to 10Gy of X-rays, the level of hyperinduced autophagic HepG2 cells was 78.2±6.1%. (c) HepG2-8960-R cells 2 days after the last maintenance irradiation
(2Gy per day). (d) At day 7 after exposure to 10Gy of X-rays, signiﬁcant induction of hyperinduced autophagic cells was not observed in HepG2-8960-R. (e) HepG2 cells
without X-rays. (f) At day 5 after exposure to 10Gy of X-rays, HepG2 cells were ﬁlled with autophagosomes (arrow head). (g) HepG2-8960-R cell 2 days after the last
maintenance irradiation (2Gy per day). (h) HepG2-8960-R cell ﬁlled with autophagosomes at day 5 after exposure to 10Gy of X-rays
X-ray-induced autophagic cell death
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Cell Death and DiseasehBeclin-1 for knockdown and siRNA-Luc for control of
transfection. HepG2 gradually died out during selection for
psiRNA-hBeclin-1 transfectant for three independent
experiments. Without irradiation, autophagosomes were not
observed both in siRNA-Luc SAS and psiRNA-hBeclin-1
SAS (Figure 8a). Five days after exposure to 10-Gy AR,
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Cell Death and Diseaseincreases of the nuclear size and autophagosomes were
observed in siRNA-Luc SAS. On the other hand, notable
increase in autophagosomes was not observed in psiRNA-
hBeclin-1 SAS. These results indicated that induction of
autophagy by AR is suppressed in psiRNA-hBeclin-1 SAS.
Compared with siRNA-Luc SAS, induction of hyperinduced
autophagic cells 5 days after exposure to AR was
signiﬁcantly suppressed in psiRNA-hBeclin-1 SAS
(Figure 8b). We next examined whether inhibition of
autophagy induces cellular radioresistance or not.
Compared with siRNA-Luc SAS radioresistance of psiRNA-
hBeclin-1 SAS was observed (Figure 8c). Growth rate of
psiRNA-hBeclin-1 SAS was slightly slower than that of
siRNA-Luc SAS (Figure 8d). Compared with un-irradiated
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Cell Death and Diseasecells, FR of 5 2-Gy suppressed cell growth of both siRNA-
Luc SAS and psiRNA-hBeclin-1 SAS but the suppression
level was not signiﬁcantly different. These results indicated
that autophagy is a determinant factor of cellular
radiosensitivity at least after AR of X-rays.
Discussion
Although radiotherapy is a well-established modality for
various cancers, appearance of radioresistant cells is one of
the major concerns. In order to understand and conquer
radioresistant tumors, we have established CRR cell
lines.
20,21 Proﬁle of radiation-induced cell death under a
microscope could be divided into two major types: cell death
with apoptotic bodies and that lacking apoptotic bodies. We
speculated that the latter was autophagic cell death. This
study revealed that apoptotic changes were observed but the
induction level of apoptosis was very low both in parental and
CRR cells. Moreover, the inhibition of apoptosis by a caspase
inhibitor, Z-VAD-FMK, did not always radiosensitize both
CRR and their parental cells. These suggest that contribution
of apoptosis to cellular radiosensitivity is not remarkable. One
of the hallmarks of cancer cells is thought to evade
apoptosis.
24,25 However, apoptosis has little or no effect on
clonogenic survival after treatment with anticancer drugs or
radiation in several tumor cell lines.
2 Recently, mounting
evidences suggest that cancer cells can commit to death by
various non-apoptotic pathways such as autophagy,
26 mitotic
catastrophe and accelerated senescence.
4 In this study,
maximum level of mitotic catastrophe within a week after AR
was approximately 10% of HepG2 cells. This observation
prompted us to examine the contribution of autophagic cell
death to cellular radiosensitivity.
Autophagic cell death known as type II programmed cell
death is independent of phagocytes and differs from
apoptosis by the presence of autophagosomes, autolyso-
somes and an intact nucleus in the cell.
27 In this study,
electron microscopic study revealed that radiation exposure-
induced characteristic morphology to autophagic cell death.
Recently, autophagy is widely investigated in the ﬁeld of
radiation oncology.
28 However, the role of autophagy for
cellular radiosensitivity remains to be elucidated. In this study,
induction of autophagy by radiation was time dependent,
which is consistent with Paglin et al.
15 But they reported that
theinduction of autophagyprotects cellsfrom radiation. In this
study, microscopic observation of LC3 immunocytochemistry
revealed cells characterized by their cytoplasm ﬁlled with
autophagosomes other than cells with a few autophago-
somes. As the frequency of this distinctive type of cells
increased after AR, we coined them ‘hyperinduced autophagic
cells’. The frequency of hyperinduced autophagic cells in
parental cells increased after AR and was signiﬁcantly higher
than in CRR cells 7 days after AR. Western blot analysis of LC3-
IIrevealedthatthenumberofautophagosomesbothatthebasal
levelandtheinducedlevelafterARwerelowerinCRRcellsthan
in parental cells. Western blotting of p62 revealed that the
autophagy function at the basal level was higher in CRR cells
than in parental cells. Both the number and the function of
autophagosomes were increased by AR in parental cells while
not obvious in CRR cells. These suggest that hyperinduced
autophagy is associated with radiation-induced cell death
albeit basal level of autophagy may contribute to the protection
of cells.
RPM induces autophagy and combination with radiation
facilitates the development of autophagy in human mammary
carcinoma MCF-7 cells accompanied with reduction of cell
survival.
29 In this study, radiosensitizing effect of RPM on
parental cells was not observed, presumably because we
used RPM at the concentration of 1/10 of the usually reported
to avoid its toxic effects. We conﬁrmed that this dose was
enough to induce autophagy after exposure to 10Gy in CRR
cells. The HDS assay with RPM showed that lower dose of
RPM than usual was enough to reverse radioresistance of
CRR cells to the levels of their corresponding parental cells.
Therefore, treatments with low dose RPM would be useful to
sensitize radioresistant tumors. Inhibition of autophagy by
3-MA did not change radiosensitivity of CRR cells, but
increased radioresistance in parental cells to the levels of
corresponding CRR cells after exposure to AR. Inhibition of
autophagy by knockdown of Beclin-1 in SAS cells also
induced radioresistance against AR. Lin et al.
30 reported that
the inhibition of autophagy promotes resistance of papillary
thyroid cancer (PTC) to radiation and the activation of
autophagy may be a useful adjunct treatment for patients
with PTC that is refractory to conventional therapy. In this
study, 3-MA did not make parental cells radioresistant to FR.
The frequency of hyperinduced autophagic cells in HepG2
was 80% at day 7 after exposure to 10Gy of AR whereas 45%
after exposure to 5 2Gy of FR. Compared with AR the lower
levelsofinducedautophagybyFRmaypartlycontributetothe
reason why the inhibition of autophagy either by 3-MA or
Beclin-1 knockdown had lower impact on the cellular radio-
resistanceofparentalcells.Inthisstudy,wefailedinobtaining
Beclin-1 knockdown HepG2. This suggests that the basal
level of autophagy is inevitable for cell survival though the
level required is cell line dependent. Basal level of autophagy
is necessary forcell survival against cellular stresses.
31 Inthis
study, the function of autophagy at the basal level for cell
protection is suggested to be higher in CRR cells than in
parental cells. Radioresistance can be acquired through
moderate dose of FR for 1 month.
20 These suggest that
factor(s) to determine whether autophagy is involved in cell
survival or cell death is different between CRR cells and
parental cells.
This study also strongly suggested that the activation of
autophagy may overcome tumor radioresistance. Those are
consistent with reports that the activation of autophagy may
yield signiﬁcant beneﬁt for cancer patients undergoing radio-
therapy.
32–34 Radioresistant tumors could be surmountable
by radiotherapy in combination with autophagy inducers such
as RPM and RAD001 (everolimus).
35
Radiation-induced cell death in HepG2 began to increase
4 days after AR with the increase in mitotic catastrophe.
Mitotic catastrophe is a well-established response to ionizing
radiation.
36 Mitotic catastrophe occurs either during or shortly
after a dysregulated/failed mitosis and is thought to be the
process to cell death.
37 In this study, mitotic ﬁgures started
increasing 3 days after AR, suggesting that cells failed to
progress mitosis go into cell death. We presented here that
about 80% of HepG2 cells after exposure to AR underwent
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catastrophe were ﬁlled with autophagosomes, suggesting
that these cells would die through autophagic cell death.
Therefore, we think the majority of radiation-induced cell
death is autophagic cell death.
This study revealed that induction of autophagy sensitized
CRRcellsboth to ARand FR.Therefore, weconclude thatthe
modality to induce autophagy can be one of the effective
approaches to conquer radioresistant tumors.
38 We started
experiments on xenografted tumors of CRR cells into nude
mice to evaluate whether the inhibition of mTOR pathway is
effective to eradicate radioresistant tumors or not.
Materials and Methods
Cell culture and chemicals. HepG2 cells derived from human liver cancer
and SAS cells from human oral cancer were obtained from the Cell Resource
Center for Biomedical Research, Institute of Development, Aging and Cancer,
Tohoku University. We established CRR cell lines, HepG2-8960-R and HepG2-R
fromHepG2,andSAS-RfromSASindependently.ForthemaintenanceoftheCRR
phenotype, FR of X-rays at 2Gy was performed every 24h. All cells used in this
study were maintained in Roswell Park Memorial Institute (RPMI) 1640 medium
(Nacalai Tesque Inc., Kyoto, Japan) supplemented with 5% fetal bovine serum
(Gibco Invitrogen Corp., Carlsbad, CA, USA) in a humidiﬁed atmosphere at 371C
with 5% CO2 in an air. In this study, acute exposure experiments were performed
with cells in the exponentially growing phase and 24h after the last maintenance
irradiation.
As an inhibitor of apoptosis, Z-VAD-FMK (20mM) was used (Promega KK,
Tokyo, Japan). For the induction of autophagy, RPM (Nacalai Tesque Inc.)
dissolved in ethanol (1mg/ml) was used at the ﬁnal concentration of 10ng/ml.
39 As
an inhibitor of autophagy, 3-MA (Sigma-Aldrich Inc., St. Louis, MO, USA) was used
at the concentration of 1mM by directly dissolved in culture medium before use.
40
These agents were administered in cell culture 24h before experiments.
Irradiation. X-ray irradiation was performed in a 150-KVp X-ray generator
(Model MBR-1520R, Hitachi, Tokyo, Japan) with a total ﬁltration of 0.5mm
aluminum plus 0.1mm copper ﬁlter at a dose rate of 1.0Gy/min. In this study, we
performed two different modes of irradiation, FR and AR. Exposure schedule of FR
consistedof2GyofX-raysevery24hupto5days(total10Gy)andARconsistedof
exposure to a single dose of 10-Gy X-rays.
Detection of apoptotic cells. To determine the percentage of cells
undergoing apoptosis, FITC annexin V/Dead Cell Apoptosis Kit (Molecular Probes,
Eugene, OR, USA) was used according to the manufacture’s protocol. Brieﬂy, after
exposure to X-rays, cells were washed with PBS and stained with annexin V.
Immediately after staining,annexinV-positive cellswere scoredunder a ﬂuorescent
microscope.
Detection of mitotic catastrophe. After exposure to X-rays, cells were
ﬁxedwith methyl alcohol andstained with giemsa solution. Cells with more than two
nucleus and micronuclei were considered as mitotic catastrophe.
Immunocytochemical detection of autophagy. Cells were seeded on
acoverslip48hbeforeradiationexposureexperiments.Atanappropriatetimeafter
irradiation, cells were rinsed twice with phosphate-buffered saline (PBS) and then
ﬁxed with 4% paraformaldehyde in PBS for 10min at room temperature (RT). Cells
were washed twice more with PBS and immersed in 100mg/ml of Digitonin (Wako
Pure Chemical Industries, Ltd., Osaka, Japan) in PBS for 15min at RT. After two
more washings with PBS, anti-LC3 primary antibody (Medical and Biological
LaboratoriesCo.,Ltd.,Nagoya,Japan)wasapplied.After1-hincubationatRT,cells
were washed three times with PBS (5min each). Cells were then incubated with
ﬂuorescein-conjugated second antibody (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA, USA) in PBS for 30min at RT. Then, cells were washed three times with
PBS (5min each) and Vectorshield (Vector Laboratories, Inc., Burlingame, CA,
USA) was mounted onto the cover slips. Autophagosomes were visualized in a
ﬂuorescence microscope (BZ-8000, Keyence, Osaka, Japan).
The HDS assay. Cell survival was determined by the modiﬁed HDS assay.
21
Brieﬂy,exponentiallygrowingcellswereseededin25cm
2ﬂasksat1 10
5perﬂask
for parental cells and 2.5 10
5 per ﬂask for CRR cells. After 24-h incubation, cells
were exposed to various doses of X-rays and incubated for another 72h.
Subsequently, 1/10 of the cells of each ﬂask were seeded into another 25cm
2 ﬂask
and incubated for further 72h. Then total number of cells in each ﬂask was counted
by Trypan blue dye exclusion test and cell survival was plotted.
Westernblotanalysis. Topreparewholecelllysate,cellswerewashedtwice
with ice-cold PBS and resuspended in a lysis buffer containing 25mM sodium
phosphate (pH7.4), 500mM NaCl, 1mM ethylenediaminetetraacetic acid (pH 8.0),
0.5% Triton-X100, 0.1% glycerol, 5mM MgCl2, 1mM dithiothreitol, 1mM
phenylmethylsulfonyl ﬂuoride and Protease Inhibitor Cocktail (Nacalai Tesque
Inc.). Cells were centrifuged for 20min at 41C and clariﬁed supernatants were
stored at  801C until use. The whole cell lysate (20mg) was electrophoresed in
sodium dodecyl sulfate polyacrylamide gel and was electroblotted onto a
polyvinylidene ﬂuoride membrane. After blocking with 5% skim milk for overnight
at 41C, the membrane was incubated for overnight with primary antibodies at 41C
and then incubated with horseradish peroxidase-conjugated secondary antibodies
(NichireiCorporation,Tokyo,Japan).Anti-cleavedcaspase-3antibodyandanti-LC3
antibodywerepurchasedfromCellSignalingTechnologyJapan,KK(Tokyo,Japan)
and anti-p62/SQSTM1 antibody from MBL Co., Ltd., Nagaya, Japan). Bands
were visualized with Chemi-Lumi One L western blotting substrate (Nacalai
Tesque Inc.).
DNA fragmentation assay. After harvesting cells including detached cells
were washed twice with ice-cold PBS and genomic DNA was extracted using
DNeasy Blood and Tissue Kit (Qiagen K K, Tokyo, Japan).
Cell survival after exposure to fractionated 2Gy of X-rays. Cells
(1 10
5) were seeded into a 25-cm
2 ﬂask (Nalge Nunc International, Rochester,
NY, USA) 48h before the ﬁrst experimental irradiation, and 24h later RPM or 3-MA
was administered. These cells were daily exposed to 2Gy of X-rays for 5
consecutive days without medium exchange. At the appropriate time point during
this experiment, total number of cells was scored and relative value of control was
calculated.
Electron microscopy. HepG2 cells grown in 60-mm culture dishes were
washed twice with PBS. Cells were ﬁxed in 100mM phosphate buffer, pH 7.4,
containing 2.5% glutaraldehyde for 30min at 41C. The cells were rinsed twice with
ice-cold PBS, post-ﬁxed in OsO4, dehydrated in graded acetone and embedded in
epoxy resin. Ultrathin sections were prepared with Ultra-microtome (Leica
Microsystems Japan, Tokyo, Japan), mounted in copper grids, and
counterstained with uranyl acetate and lead citrate. Photographs were obtained
using transmission electron microscope (Hitachi High-Technologies Corporation,
Tokyo, Japan).
Inhibition of autophagy by Beclin-1 knockdown. In order to inhibit
autophagy, a psiRNA-hBeclin-1 Kit was used according to the manufacture’s
protocol (InvivoGen, San Diego, CA, USA). Brieﬂy, cells were transfected
with expression vector using HilyMax (Dojindo, Kumamoto, Japan). These cells
were cultured in RPMI medium containing 5% fetal bovine serum and Zeocin
(100mg/ml, InvivoGen) for 2 weeks. The viable cell preparation was used for
experiments.
Statistical analysis. At each data point, the mean and S.D. were calculated
and statistically analyzed using Student’s t-test.
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